Track topics on Twitter Track topics that are important to you
House Democrats have started what they called an "in-depth" investigation into the pricing of drugs for neurological condition multiple sclerosis, the latest attempt by U.S. politicians to pressure manufacturers to lower costs. Biogen Inc. , Sanofi, Novartis AG, Roche Holding AG, Bayer AG, Merck KGaA's EMD Serono unit and Teva Phamaceuticals Industries Ltd. -- received letters requesting information on pricing strategies from Elijah Cummings and Peter Welch, two representatives who sit on the House Committee on Oversight and Government Reform.
Original Article: House Democrats Start Probe Into Multiple Sclerosis Drug PricesNEXT ARTICLE
Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...